-
ÐÇ¿ÕÊÓƵ Website
- Page could not be found
Page could not be found
Here are some recommended pages that may interested you
International comparisons in medicines spending and the link to competitiveness
Kim Assender, Director of Commercial Policy and Analysis at the ÐÇ¿ÕÊÓƵ, discusses a new report from IQVIA and what it says about the right strategic level of spending on medicines to deliver the best outcomes for patients while supporting cash-strapped health systems and delivering wider economic growth.
VPAG payment rate for newer medicines will be 14.5% in 2026
The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 per cent in 2025.
Decline in commercial clinical trial recruitment selling patients short, says ÐÇ¿ÕÊÓƵ
The low number of patients recruited, together with slow set-up times, is raising costs and lowering the efficiency of industry clinical trials in the UK.
ÐÇ¿ÕÊÓƵ Annual Conference 2026
ÐÇ¿ÕÊÓƵ’s flagship annual conference will be taking place in Central London on 23 April 2026.
Last modified: 31 January 2024
Last reviewed: 31 January 2024